misappropriation of trade secrets

By Memorandum Order entered by The Honorable Richard G. Andrews in Lithero, LLC v. AstraZeneca Pharmaceuticals LP, Civil Action No. 19-2320-RGA (D.Del. August 13, 2020), the Court found that Plaintiff failed to plead a plausible trade secret misappropriation claim under the federal Defend Trade Secrets Act (“DTSA”) despite the fact that the Court had

By Memorandum Order entered by The Honorable Sue L. Robinson in Adtile Technologies, Inc. v. Perion Network Ltd., et al., Civil Action No. 15-1193-SLR (D.Del., June 23, 2016), the Court denied plaintiff Adtile Technologies, Inc.’s motion for preliminary injunction after concluding that Adtile had not shown likelihood of success on the merits of the

By Report and Recommendation entered by The Honorable Christopher J. Burke in Eastman Chemical Co. v. Alphapet Inc., et al., Civil Action No. 09-971-LPS-CJB (D.Del., November 10, 2011), the Court granted in part defendants’ Rule 12(b)(6) motion to dismiss the breach of contract and trade secret misappropriation claims asserted by Plaintiff. The Complaint alleged